» Articles » PMID: 33440908

Advances in Bio-Based Polymers for Colorectal CancerTreatment: Hydrogels and Nanoplatforms

Overview
Journal Gels
Date 2021 Jan 14
PMID 33440908
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Adenocarcinoma of the colon is the most common malignant neoplasia of the gastrointestinal tract and is a major contributor to mortality worldwide. Invasiveness and metastatic behavior are typical of malignant tumors and, because of its portal drainage, the liver is the closest capillary bed available in this case, hence the common site of metastatic dissemination. Current therapies forecast total resection of primary tumor when possible and partial liver resection at advanced stages, along with systemic intravenous therapies consisting of chemotherapeutic agents such as 5-fluorouracil. These cures are definitely not exempt from drawbacks and heavy side effects. Biocompatible polymeric networks, both in colloids and bulk forms, able to absorb large quantities of water and load a variety of molecules-belong to the class of innovative drug delivery systems, thus suitable for the purpose and tunable on each patient can represent a promising alternative. Indeed, the implantation of polymeric scaffolds easy to synthesize can substitute chemotherapy and combination therapies scheduling, shortening side effects. Moreover, they do not require a surgical removal thanks to spontaneous degradation and guarantees an extended and regional cargo release, maintaining high drug concentrations. In this review, we focus our attention on the key role of polymeric networks as drug delivery systems potentially able to counteract this dramatic disease.

Citing Articles

Serum-Exosome-Derived miRNAs Serve as Promising Biomarkers for HCC Diagnosis.

Rui T, Zhang X, Guo J, Xiang A, Tang N, Liu J Cancers (Basel). 2023; 15(1).

PMID: 36612201 PMC: 9818484. DOI: 10.3390/cancers15010205.


Nanoparticles Loaded with Platinum Drugs for Colorectal Cancer Therapy.

Buyana B, Naki T, Alven S, Aderibigbe B Int J Mol Sci. 2022; 23(19).

PMID: 36232561 PMC: 9569963. DOI: 10.3390/ijms231911261.


Imatinib Mesylate-Loaded Rosin/Cinnamon Oil-Based In Situ Forming Gel against Colorectal Cancer Cells.

Khaing E, Intaraphairot T, Mahadlek J, Okonogi S, Pichayakorn W, Phaechamud T Gels. 2022; 8(9).

PMID: 36135239 PMC: 9498735. DOI: 10.3390/gels8090526.


Recent Advances in Chitosan and its Derivatives in Cancer Treatment.

Ding J, Guo Y Front Pharmacol. 2022; 13:888740.

PMID: 35694245 PMC: 9178414. DOI: 10.3389/fphar.2022.888740.


Recent advances in targeted drug delivery systems for resistant colorectal cancer.

Sharifi-Azad M, Fathi M, Cho W, Barzegari A, Dadashi H, Dadashpour M Cancer Cell Int. 2022; 22(1):196.

PMID: 35590367 PMC: 9117978. DOI: 10.1186/s12935-022-02605-y.


References
1.
Xu K, Lee F, Gao S, Chung J, Yano H, Kurisawa M . Injectable hyaluronic acid-tyramine hydrogels incorporating interferon-α2a for liver cancer therapy. J Control Release. 2013; 166(3):203-10. DOI: 10.1016/j.jconrel.2013.01.008. View

2.
Perez-Madrigal M, Shaw J, Arno M, Hoyland J, Richardson S, Dove A . Robust alginate/hyaluronic acid thiol-yne click-hydrogel scaffolds with superior mechanical performance and stability for load-bearing soft tissue engineering. Biomater Sci. 2019; 8(1):405-412. DOI: 10.1039/c9bm01494b. View

3.
Xu X, Liu C, Liu Y, Li N, Guo X, Wang S . Encapsulated human hepatocellular carcinoma cells by alginate gel beads as an in vitro metastasis model. Exp Cell Res. 2013; 319(14):2135-44. DOI: 10.1016/j.yexcr.2013.05.013. View

4.
Kumar M, Muzzarelli R, Muzzarelli C, Sashiwa H, Domb A . Chitosan chemistry and pharmaceutical perspectives. Chem Rev. 2004; 104(12):6017-84. DOI: 10.1021/cr030441b. View

5.
Chen C, Chen S, Mao S, Tsai M, Chou P, Liao C . Injectable thermosensitive hydrogel containing hyaluronic acid and chitosan as a barrier for prevention of postoperative peritoneal adhesion. Carbohydr Polym. 2017; 173:721-731. DOI: 10.1016/j.carbpol.2017.06.019. View